C

Celeris Therapeutics

17 employees

Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
PROTAC
Artificial Intelligence
PPI
Geometric Deep Learning
Pharmaceutical
Protein-Ligand Interaction
Protein-Protein-Interaction
Drug Discovery
Protein
Deep Learning
Molecular glue
Drug Design
Drug Builder
Life Science
Information Technology
Graph Neural Networks

Date founded

2021

Funding rounds raised

Total raised

$3.4M

from 6 investors over 6 rounds

C

Celeris Therapeutics raised $3.4M on February 10, 2022

Investors: Pace Ventures, i&i Prague, Longevitytech.fund and R42 Group

C

Celeris Therapeutics raised $471K on March 28, 2021

Investors: Longevitytech.fund and R42 Group

FAQ